{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T02:36:25Z","timestamp":1791426985085,"version":"4.3.3"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2016,3,3]],"date-time":"2016-03-03T00:00:00Z","timestamp":1456963200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004488","name":"Hrvatska Zaklada za Znanost","doi-asserted-by":"publisher","award":["8193"],"award-info":[{"award-number":["8193"]}],"id":[{"id":"10.13039\/501100004488","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Virol"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1007\/s00705-016-2801-3","type":"journal-article","created":{"date-parts":[[2016,3,3]],"date-time":"2016-03-03T02:19:56Z","timestamp":1456971596000},"page":"1455-1467","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Stability, biophysical properties and effect of ultracentrifugation and diafiltration on measles virus and mumps virus"],"prefix":"10.1007","volume":"161","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5905-0692","authenticated-orcid":false,"given":"Dora","family":"Sviben","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dubravko","family":"For\u010di\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tihana","family":"Kurtovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beata","family":"Halassy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marija","family":"Brgles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,3,3]]},"reference":[{"key":"2801_CR1","first-page":"957","volume-title":"Fields Virol","author":"RA Lamb","year":"2013","unstructured":"Lamb RA, Parks GD (2013) Paramixoviridae. In: Knipe DM, Howley PM (eds) Fields Virol, 6th edn. Lippincot Williams & Wilkins, Philadelphia, pp 957\u2013995","edition":"6"},{"key":"2801_CR2","first-page":"107","volume":"53","author":"E Daikoku","year":"2007","unstructured":"Daikoku E, Morita C, Kohno T, Sano K (2007) Analysis of morphology and infectivity of measles virus particles. Bull Osaka Med Coll 53:107\u2013114","journal-title":"Bull Osaka Med Coll"},{"key":"2801_CR3","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3844\/ajbbsp.2013.243.254","volume":"9","author":"K Weiss","year":"2013","unstructured":"Weiss K, Salzig D, R\u00f6der Y et al (2013) Influence of process conditions on measles virus stability. Am J Biochem Biotechnol 9:243\u2013254","journal-title":"Am J Biochem Biotechnol"},{"key":"2801_CR4","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/path.1700670130","volume":"67","author":"BG Ray","year":"1954","unstructured":"Ray BG, Swain RH (1954) An investigation of the mumps virus by electron microscopy. J Pathol Bacteriol 67:247\u2013252","journal-title":"J Pathol Bacteriol"},{"key":"2801_CR5","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1128\/JVI.1.2.415-429.1967","volume":"1","author":"H Duc-Nguyen","year":"1967","unstructured":"Duc-Nguyen H, Rosenblum EN (1967) Immuno-electron microscopy of the morphogenesis of mumps virus. J Virol 1:415\u2013429","journal-title":"J Virol"},{"key":"2801_CR6","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.1128\/JVI.03741-13","volume":"88","author":"S Bose","year":"2014","unstructured":"Bose S, Song AS, Jardetzky TS, Lamb RA (2014) Fusion activation through attachment protein stalk domains indicates a conserved core mechanism of paramyxovirus entry into cells. J Virol 88:3925\u20133941","journal-title":"J Virol"},{"key":"2801_CR7","doi-asserted-by":"crossref","first-page":"13619","DOI":"10.1128\/JVI.02256-13","volume":"87","author":"A Talekar","year":"2013","unstructured":"Talekar A, Moscona A, Porotto M (2013) Measles virus fusion machinery activated by sialic acid binding globular domain. J Virol 87:13619\u201313627","journal-title":"J Virol"},{"key":"2801_CR8","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3844\/ajbbsp.2012.81.98","volume":"8","author":"K Weiss","year":"2012","unstructured":"Weiss K, Salzig D, M\u00fchlebach MD et al (2012) Key parameters of measles virus production for oncolytic virotherapy. Am J Biochem Biotechnol 8:81\u201398","journal-title":"Am J Biochem Biotechnol"},{"key":"2801_CR9","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/0042-6822(59)90186-2","volume":"7","author":"FL Black","year":"1959","unstructured":"Black FL (1959) Growth and stability of measles virus. Virology 7:184\u2013192","journal-title":"Virology"},{"key":"2801_CR10","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0042-6822(62)90092-2","volume":"17","author":"A Kohn","year":"1962","unstructured":"Kohn A, Yassky D (1962) Growth of measles virus in KB cells. Virology 17:157\u2013163","journal-title":"Virology"},{"key":"2801_CR11","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1128\/JB.90.1.132-135.1965","volume":"90","author":"F Rapp","year":"1965","unstructured":"Rapp F, Butel JS, Wallis C (1965) Protection of measles virus by sulfate ions against thermal inactivation. J Bacteriol 90:132\u2013135","journal-title":"J Bacteriol"},{"key":"2801_CR12","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/0042-6822(61)90370-1","volume":"15","author":"AP Waterson","year":"1961","unstructured":"Waterson AP, Cruickshank JG, Laurence GD, Kanarek AD (1961) The nature of measles virus. Virology 15:379\u2013382","journal-title":"Virology"},{"key":"2801_CR13","doi-asserted-by":"crossref","first-page":"561","DOI":"10.4049\/jimmunol.60.4.561","volume":"60","author":"ML Weil","year":"1948","unstructured":"Weil ML, Beard D, Sharp DG, Beard JW (1948) Purification, pH stability and culture of the mumps virus. J Immunol 60:561\u2013582","journal-title":"J Immunol"},{"key":"2801_CR14","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.biotechadv.2005.12.001","volume":"24","author":"M de las Mercedes Segura","year":"2006","unstructured":"de las Mercedes Segura M, Kamen A, Garnier A (2006) Downstream processing of oncoretroviral and lentiviral gene therapy vectors. Biotechnol Adv 24:321\u2013337","journal-title":"Biotechnol Adv"},{"key":"2801_CR15","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.jbiotec.2006.07.028","volume":"127","author":"T Rodrigues","year":"2007","unstructured":"Rodrigues T, Carrondo MJT, Alves PM, Cruz PE (2007) Purification of retroviral vectors for clinical application: Biological implications and technological challenges. J Biotechnol 127:520\u2013541","journal-title":"J Biotechnol"},{"key":"2801_CR16","doi-asserted-by":"crossref","first-page":"8033","DOI":"10.1073\/pnas.90.17.8033","volume":"90","author":"JC Burns","year":"1993","unstructured":"Burns JC, Friedmann T, Driever W et al (1993) Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells. Proc Natl Acad Sci USA 90:8033\u20138037","journal-title":"Proc Natl Acad Sci USA"},{"key":"2801_CR17","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1128\/JVI.76.3.1488-1495.2002","volume":"76","author":"WR Beyer","year":"2002","unstructured":"Beyer WR, Westphal M, Ostertag W, von Laer D (2002) Oncoretrovirus and lentivirus vectors pseudotyped with lymphocytic choriomeningitis virus glycoprotein: generation, concentration, and broad host range. J Virol 76:1488\u20131495","journal-title":"J Virol"},{"key":"2801_CR18","doi-asserted-by":"crossref","first-page":"9995","DOI":"10.1128\/JVI.75.20.9995-9999.2001","volume":"75","author":"J Gatlin","year":"2001","unstructured":"Gatlin J, Melkus MW, Padgett A et al (2001) Engraftment of NOD\/SCID mice with human CD34(+) cells transduced by concentrated oncoretroviral vector particles pseudotyped with the feline endogenous retrovirus (RD114) envelope protein. J Virol 75:9995\u20139999","journal-title":"J Virol"},{"key":"2801_CR19","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1038\/sj.gt.3301188","volume":"7","author":"J Reiser","year":"2000","unstructured":"Reiser J (2000) Production and concentration of pseudotyped HIV-1-based gene transfer vectors. Gene Ther 7:910\u2013913","journal-title":"Gene Ther"},{"key":"2801_CR20","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0166-0934(91)90186-4","volume":"32","author":"M Njayou","year":"1991","unstructured":"Njayou M, Quash G (1991) Purification of measles virus by affinity chromatography and by ultracentrifugation: a comparative study. J Virol Methods 32:67\u201377","journal-title":"J Virol Methods"},{"key":"2801_CR21","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1002\/bit.25545","volume":"112","author":"P Nestola","year":"2015","unstructured":"Nestola P, Peixoto C, Silva RRJS et al. (2015) Improved virus purification processes for vaccines and gene therapy. Biotechnol Bioeng 112:843\u2013857","journal-title":"Biotechnol Bioeng"},{"key":"2801_CR22","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jchromb.2005.05.022","volume":"823","author":"DP Nayak","year":"2005","unstructured":"Nayak DP, Lehmann S, Reichl U (2005) Downstream processing of MDCK cell-derived equine influenza virus. J Chromatogr B 823:75\u201381","journal-title":"J Chromatogr B"},{"key":"2801_CR23","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1089\/hum.1993.4.5-609","volume":"4","author":"RW Paul","year":"1993","unstructured":"Paul RW, Morris DAN, Hess BW et al (1993) Increased viral titer through concentration of viral harvests from retroviral packaging lines. Hum Gene Ther 4:609\u2013615","journal-title":"Hum Gene Ther"},{"key":"2801_CR24","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1093\/nar\/24.8.1576","volume":"24","author":"DL Miller","year":"1996","unstructured":"Miller DL, Meikle PJ, Anson DS (1996) A rapid and efficient method for concentration of small volumes of retroviral supernatant. Nucleic Acids Res 24:1576\u20131577","journal-title":"Nucleic Acids Res"},{"key":"2801_CR25","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1089\/hgtb.2012.058","volume":"23","author":"MM Segura","year":"2012","unstructured":"Segura MM, Puig M, Monfar M, Chill\u00f3n M (2012) Chromatography purification of canine adenoviral vectors. Hum Gene Ther Methods 23:182\u2013197","journal-title":"Hum Gene Ther Methods"},{"key":"2801_CR26","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.desal.2009.02.027","volume":"245","author":"D Nehring","year":"2009","unstructured":"Nehring D, Poertner R, Schweizer M et al (2009) Integrated inline filtration: a method to produce highly concentrated retroviral vector titer supernatant. Desalination 245:614\u2013620","journal-title":"Desalination"},{"key":"2801_CR27","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1089\/hum.1994.5.1-19","volume":"5","author":"H Kotani","year":"1994","unstructured":"Kotani H, Newton PB, Zhang S et al (1994) Improved methods of retroviral vector transduction and production for gene therapy. Hum Gene Ther 5:19\u201328","journal-title":"Hum Gene Ther"},{"key":"2801_CR28","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1038\/gt.2009.33","volume":"16","author":"T Vicente","year":"2009","unstructured":"Vicente T, Peixoto C, Carrondo MJT, Alves PM (2009) Purification of recombinant baculoviruses for gene therapy using membrane processes. Gene Ther 16:766\u2013775","journal-title":"Gene Ther"},{"key":"2801_CR29","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/BF01309456","volume":"139","author":"M Makino","year":"1994","unstructured":"Makino M, Ishikawa G, Yamaguchi K et al (1994) Concentration of live retrovirus with a regenerated cellulose hollow fiber, BMM. Arch Virol 139:87\u201396","journal-title":"Arch Virol"},{"key":"2801_CR30","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/bit.10388","volume":"80","author":"M Kuiper","year":"2002","unstructured":"Kuiper M, Sanches RM, Walford JA, Slater NKH (2002) Purification of a functional gene therapy vector derived from moloney murine leukaemia virus using membrane filtration and ceramic hydroxyapatite chromatography. Biotechnol Bioeng 80:445\u2013453","journal-title":"Biotechnol Bioeng"},{"key":"2801_CR31","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s00253-002-0976-x","volume":"59","author":"L Maranga","year":"2002","unstructured":"Maranga L, Rueda P, Antonis A et al (2002) Large scale production and downstream processing of a recombinant porcine parvovirus vaccine. Appl Microbiol Biotechnol 59:45\u201350","journal-title":"Appl Microbiol Biotechnol"},{"key":"2801_CR32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.virusres.2013.03.015","volume":"175","author":"E Papanikolaou","year":"2013","unstructured":"Papanikolaou E, Kontostathi G, Drakopoulou E et al (2013) Characterization and comparative performance of lentiviral vector preparations concentrated by either one-step ultrafiltration or ultracentrifugation. Virus Res 175:1\u201311","journal-title":"Virus Res"},{"key":"2801_CR33","unstructured":"Carr B, Wright M (2012) Nanoparticle tracking analysis: a review of applications and usage 2010\u20132012.\u00a0Nanosight Ltd, pp\u00a01\u2013193"},{"key":"2801_CR34","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1007\/s11095-010-0073-2","volume":"27","author":"V Filipe","year":"2010","unstructured":"Filipe V, Hawe A, Jiskoot W (2010) Critical evaluation of nanoparticle tracking analysis (NTA) by NanoSight for the measurement of nanoparticles and protein aggregates. Pharm Res 27:796\u2013810","journal-title":"Pharm Res"},{"key":"2801_CR35","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1016\/j.vaccine.2009.11.049","volume":"28","author":"D Forcic","year":"2010","unstructured":"Forcic D, Ko\u0161uti\u0107-Gulija T, \u0160antak M et al (2010) Comparisons of mumps virus potency estimates obtained by 50\u00a0% cell culture infective dose assay and plaque assay. Vaccine 28:1887\u20131892","journal-title":"Vaccine"},{"key":"2801_CR36","unstructured":"World Health Organization (1997) Live measles virus vaccine. In: Manual of laboratory methods. Document WHO\/VSQ\/97.04. World Health Organization, Geneva, pp 79\u201382"},{"key":"2801_CR37","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1021\/ac60052a025","volume":"23","author":"RB Dean","year":"1951","unstructured":"Dean RB, Dixon WJ (1951) Simplified statistics for small numbers of observations. Anal Chem 23:636\u2013638","journal-title":"Anal Chem"},{"key":"2801_CR38","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/S0140-6736(08)60419-5","volume":"371","author":"A Hviid","year":"2008","unstructured":"Hviid A, Rubin S, M\u00fchlemann K (2008) Mumps. Lancet 371:932\u2013944","journal-title":"Lancet"},{"key":"2801_CR39","doi-asserted-by":"crossref","first-page":"350","DOI":"10.4161\/hv.4.5.5863","volume":"4","author":"J Kissmann","year":"2008","unstructured":"Kissmann J, Ausar SF, Rudolph A et al (2008) Stabilization of measles virus for vaccine formulation. Hum Vaccin 4:350\u2013359","journal-title":"Hum Vaccin"},{"key":"2801_CR40","doi-asserted-by":"crossref","first-page":"308","DOI":"10.3181\/00379727-68-16466P","volume":"68","author":"ML Weil","year":"1948","unstructured":"Weil ML, Beard D, Beard JW (1948) pH stability, response to antibiotics and factors influencing egg-culture of mumps virus. Exp Biol Med 68:308\u2013309","journal-title":"Exp Biol Med"},{"key":"2801_CR41","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/BF01315013","volume":"61","author":"R Leprat","year":"1979","unstructured":"Leprat R, Aymard M (1979) Selective inactivation of hemagglutinin and neuraminidase on mumps virus. Arch Virol 61:273\u2013281","journal-title":"Arch Virol"},{"key":"2801_CR42","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.biologicals.2014.08.006","volume":"42","author":"S Rani","year":"2014","unstructured":"Rani S, Gogoi P, Kumar S (2014) Spectrum of newcastle disease virus stability in gradients of temperature and pH. Biologicals 42:351\u2013354","journal-title":"Biologicals"},{"key":"2801_CR43","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1126\/science.105.2731.477","volume":"105","author":"HE Moses","year":"1947","unstructured":"Moses HE, Brandly CA, Jones EE (1947) The pH stability of viruses of Newcastle disease and fowl plague. Science 105:477\u2013479","journal-title":"Science"},{"key":"2801_CR44","first-page":"333","volume":"34","author":"MK Tolba","year":"1959","unstructured":"Tolba MK, Eskarous JK (1959) pH-stability patterns of some strains of Newcastle disease and fowl-plague viruses. Arch Microbiol 34:333\u2013338","journal-title":"Arch Microbiol"},{"key":"2801_CR45","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1006\/viro.1999.9841","volume":"260","author":"K San Rom\u00e1n","year":"1999","unstructured":"San Rom\u00e1n K, Villar E, Munoz-Barroso I (1999) Acidic pH enhancement of the fusion of Newcastle disease virus with cultured cells. Virology 260:329\u2013341","journal-title":"Virology"},{"key":"2801_CR46","doi-asserted-by":"crossref","first-page":"5031","DOI":"10.1016\/j.vaccine.2011.04.079","volume":"29","author":"LD Schlehuber","year":"2011","unstructured":"Schlehuber LD, McFadyen IJ, Shu Y et al (2011) Towards ambient temperature-stable vaccines: the identification of thermally stabilizing liquid formulations for measles virus using an innovative high-throughput infectivity assay. Vaccine 29:5031\u20135039","journal-title":"Vaccine"},{"key":"2801_CR47","unstructured":"Barme M (1985) Stabilizing agents for live viruses for preparing vaccines, and stabilized vaccines containing said stabilized agents. US patent: available at http:\/\/www.google.com\/patents\/US45005 . Accessed 29 Sept 2015"},{"key":"2801_CR48","doi-asserted-by":"crossref","first-page":"408","DOI":"10.2174\/138920109788488851","volume":"10","author":"C Lange","year":"2009","unstructured":"Lange C, Rudolph R (2009) Suppression of protein aggregation by L-arginine. Curr Pharm Biotechnol 10:408\u2013414","journal-title":"Curr Pharm Biotechnol"},{"key":"2801_CR49","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.chroma.2005.07.086","volume":"1094","author":"D Ejima","year":"2005","unstructured":"Ejima D, Yumioka R, Arakawa T, Tsumoto K (2005) Arginine as an effective additive in gel permeation chromatography. J Chromatogr A 1094:49\u201355","journal-title":"J Chromatogr A"},{"key":"2801_CR50","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.pep.2004.04.009","volume":"36","author":"T Arakawa","year":"2004","unstructured":"Arakawa T, Philo JS, Tsumoto K et al (2004) Elution of antibodies from a protein-A column by aqueous arginine solutions. Protein Expr Purif 36:244\u2013248","journal-title":"Protein Expr Purif"},{"key":"2801_CR51","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/jps.2600840609","volume":"84","author":"M Katakam","year":"1995","unstructured":"Katakam M, Bell LN, Banga AK (1995) Effect of surfactants on the physical stability of recombinant human growth hormone. J Pharm Sci 84:713\u2013716","journal-title":"J Pharm Sci"},{"key":"2801_CR52","doi-asserted-by":"crossref","first-page":"11916","DOI":"10.1128\/JVI.78.21.11916-11925.2004","volume":"78","author":"Y Beaus\u00e9jour","year":"2004","unstructured":"Beaus\u00e9jour Y, Tremblay MJ (2004) Interaction between the cytoplasmic domain of ICAM-1 and Pr55 Gag leads to acquisition of host ICAM-1 by human immunodeficiency virus type 1. J Virol 78:11916\u201311925","journal-title":"J Virol"},{"key":"2801_CR53","doi-asserted-by":"crossref","first-page":"12708","DOI":"10.1128\/JVI.00886-12","volume":"86","author":"M Biswas","year":"2012","unstructured":"Biswas M, Johnson JB, Kumar SRP et al (2012) Incorporation of host complement regulatory proteins into Newcastle disease virus enhances complement evasion. J Virol 86:12708\u201312716","journal-title":"J Virol"},{"key":"2801_CR54","doi-asserted-by":"crossref","first-page":"6577","DOI":"10.1128\/JVI.79.11.6577-6587.2005","volume":"79","author":"R Cantin","year":"2005","unstructured":"Cantin R, M\u00e9thot S, Tremblay MJ (2005) Plunder and stowaways: incorporation of cellular proteins by enveloped viruses. J Virol 79:6577\u20136587","journal-title":"J Virol"},{"key":"2801_CR55","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/372359a0","volume":"372","author":"EK Franke","year":"1994","unstructured":"Franke EK, Yuan HE, Luban J (1994) Specific incorporation of cyclophilin A into HIV-1 virions. Nature 372:359\u2013362","journal-title":"Nature"},{"key":"2801_CR56","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1099\/0022-1317-71-4-775","volume":"71","author":"SA Moyer","year":"1990","unstructured":"Moyer SA, Baker SC, Horikami SM (1990) Host cell proteins required for measles virus reproduction. J Gen Virol 71:775\u2013783","journal-title":"J Gen Virol"},{"key":"2801_CR57","first-page":"1","volume":"4","author":"ML Shaw","year":"2008","unstructured":"Shaw ML, Stone KL, Colangelo CM et al (2008) Cellular proteins in influenza virus particles. PLoS Pathog 4:1\u201313","journal-title":"PLoS Pathog"},{"key":"2801_CR58","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1021\/bp025599g","volume":"19","author":"P Lotfian","year":"2003","unstructured":"Lotfian P, Levy MS, Coffin RS et al (2003) Impact of process conditions on the centrifugal recovery of a disabled herpes simplex virus. Biotechnol Prog 19:209\u2013215","journal-title":"Biotechnol Prog"},{"key":"2801_CR59","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1472-6750-11-55","volume":"11","author":"K Zimmermann","year":"2011","unstructured":"Zimmermann K, Scheibe O, Kocourek A et al (2011) Highly efficient concentration of lenti- and retroviral vector preparations by membrane adsorbers and ultrafiltration. BMC Biotechnol 11:55\u201367","journal-title":"BMC Biotechnol"},{"key":"2801_CR60","doi-asserted-by":"crossref","first-page":"e115802","DOI":"10.1371\/journal.pone.0115802","volume":"9","author":"P Nestola","year":"2014","unstructured":"Nestola P, Martins DL, Peixoto C et al (2014) Evaluation of novel large cut-off ultrafiltration membranes for adenovirus serotype 5 (Ad5) concentration. PLoS One 9:e115802","journal-title":"PLoS One"}],"container-title":["Archives of Virology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00705-016-2801-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00705-016-2801-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00705-016-2801-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T03:12:27Z","timestamp":1692241947000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00705-016-2801-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,3]]},"references-count":60,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["2801"],"URL":"https:\/\/doi.org\/10.1007\/s00705-016-2801-3","relation":{},"ISSN":["0304-8608","1432-8798"],"issn-type":[{"value":"0304-8608","type":"print"},{"value":"1432-8798","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,3]]}}}